EVR Evraz PLC

EVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023

EVRAZ plc (EVR)
EVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023

08-Dec-2022 / 11:17 MSK
Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT OR THE CONSENT SOLICITATION MEMORANDUM.

EVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023

London, 8 December 2022 – on 15 November 2022, EVRAZ plc (the “Issuer”) announced a consent solicitation in relation to the outstanding U.S.$750,000,000 5.375 per cent. notes due 2023 issued by the Issuer (Regulation S Notes: Common Code 153391572 / ISIN XS1533915721; Rule 144A Notes: Common Code 111731110 / ISIN US30050AAG85 / CUSIP 30050AAG8) (the “Notes”) on the terms and subject to the conditions set forth in the consent solicitation memorandum dated 15 November 2022 (the “Consent Solicitation Memorandum”). Capitalised terms used, but not defined herein, shall have the meanings given to them in the Consent Solicitation Memorandum.

The Appointment Extraordinary Resolution and the Amendment Extraordinary Resolution were each passed at the Meeting of Noteholders held on 7 December 2022. Each of the Appointment and the Amendments will become effective upon execution of (i) the Deed of Appointment and (ii) the Supplemental Trust Deed, which will be separately notified to investors by the Issuer.

The Issuer extends its gratitude for the support and cooperation demonstrated by investors, which has been reflected in the successful results of the Consent Solicitation.

 

Questions and requests for assistance in connection with the Consent Solicitation should be directed to the Information and Tabulation Agent:

Limited liability company “Legal Capital Investor Services”

Address:  10 Krivokolenny lane, bldg. 6, Moscow 101000, Russia

Email:   

Phone:    7

Website:  

 

###

For further information:

 

Investor Relations

 



ISIN: GB00B71N6K86, XS1533915721, XS1843443273,
Category Code: MSCH
TIDM: EVR
LEI Code: 5493005B7DAN39RXLK23
OAM Categories: 2.2. Inside information
Sequence No.: 207086
EQS News ID: 1507855

 
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1507855&application_name=news&site_id=research_pool
EN
08/12/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Evraz PLC

MarketLine Department
  • MarketLine Department

Aperam SA - Company Profile and SWOT Analysis

Summary Aperam SA - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Aperam SA (Aperam) is a steel manufacturing company. It carries out the production of stainless and specialty steel products. Aperam offers high value-added specialty products, including grain oriented and no...

MarketLine Department
  • MarketLine Department

Aperam S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances

Summary Marketline's Aperam S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Aperam S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports off...

 PRESS RELEASE

DISCONTINUATION OF DISCLOSURE VIA PRIMARY INFORMATION PROVIDER

EVRAZ plc (EVR) DISCONTINUATION OF DISCLOSURE VIA PRIMARY INFORMATION PROVIDER 28-Feb-2023 / 10:00 MSK The issuer is solely responsible for the content of this announcement. DISCONTINUATION OF DISCLOSURE VIA PRIMARY INFORMATION PROVIDER   28 February 2023 - EVRAZ plc (“EVRAZ” or the “Company”) announces that starting from 1 March 2023 the Company will not be able to release regulatory news announcements via a primary information provider (“PIP”). In May 2022, EVRAZ was informed by the RNS, its PIP at that time, about discontinuation of its services for EVRAZ due to sanctions...

 PRESS RELEASE

CLARIFICATION ON ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 20...

EVRAZ plc (EVR) CLARIFICATION ON ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 2022 27-Feb-2023 / 10:00 MSK The issuer is solely responsible for the content of this announcement. CLARIFICATION ON ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 2022   27 February 2023 - EVRAZ plc (“EVRAZ” or the “Company”) announces that the Company has not been able to engage an auditor in respect of its most recent financial year ended 31 December 2022 in light of UK sanctions imposed against EVRAZ. The Company has made multiple enquiries to UK audit firms and no one expressed willi...

 PRESS RELEASE

EVRAZ plc announces that the Appointment and the Amendments adopted as...

EVRAZ plc (EVR) EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective 28-Dec-2022 / 10:30 MSK Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT OR THE CONSENT SOLICITA...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch